HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michel Chrétien Selected Research

tetrapeptide carbamate

5/2005Furin-like proprotein convertases are central regulators of the membrane type matrix metalloproteinase-pro-matrix metalloproteinase-2 proteolytic cascade in atherosclerosis.
4/2005Immunohistochemical localization of subtilisin/kexin-like proprotein convertases in human atherosclerosis.
2/2004Endoproteolytic activation of alpha(v) integrin by proprotein convertase PC5 is required for vascular smooth muscle cell adhesion to vitronectin and integrin-dependent signaling.
6/2003The secretory proprotein convertases furin, PC5, and PC7 activate VEGF-C to induce tumorigenesis.
3/2003Coordinated regulation and colocalization of alphav integrin and its activating enzyme proprotein convertase PC5 in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michel Chrétien Research Topics

Disease

7Neoplasms (Cancer)
10/2009 - 06/2002
6Infections
01/2022 - 01/2007
5Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 10/2008
4Carcinogenesis
10/2009 - 04/2003
4Atherosclerosis
10/2006 - 02/2004
3Inflammation (Inflammations)
01/2021 - 01/2018
3Vascular Remodeling
08/2004 - 03/2003
2Malaria
01/2020 - 01/2018
2Hyperinsulinism (Hyperinsulinemia)
01/2018 - 09/2015
2Coronary Artery Disease (Coronary Atherosclerosis)
01/2018 - 07/2015
2Hypercholesterolemia
01/2014 - 09/2012
2Infertility (Sterility)
10/2008 - 10/2006
2Communicable Diseases (Infectious Diseases)
10/2008 - 10/2006
2Neoplasm Metastasis (Metastasis)
11/2005 - 06/2002
2Atherosclerotic Plaque (Atheroma)
05/2005 - 02/2004
2Carcinoma (Carcinomatosis)
06/2003 - 04/2003
1COVID-19
01/2022
1Human Influenza (Influenza)
01/2022
1Overweight
01/2021
1Simpson-Golabi-Behmel syndrome
01/2021
1Type 2 Diabetes Mellitus (MODY)
01/2021
1Hypertriglyceridemia
01/2021
1Hyperlipidemias (Hyperlipidemia)
01/2018
1Sepsis (Septicemia)
01/2018
1Ebola Hemorrhagic Fever
01/2016
1Insulin Resistance
09/2015
1Glucose Intolerance
01/2015
1Insulinoma
10/2013
1Adenocarcinoma
10/2009
1Breast Neoplasms (Breast Cancer)
10/2009
1Chikungunya Fever
08/2008
1Growth Disorders
06/2007
1Parasitic Diseases (Parasitic Disease)
01/2007
1Neurodegenerative Diseases (Neurodegenerative Disease)
10/2006
1Obesity
10/2006
1Colonic Neoplasms (Colon Cancer)
11/2005
1Virus Diseases (Viral Diseases)
01/2005
1Alzheimer Disease (Alzheimer's Disease)
12/2004
1Neointima
03/2003
1Lassa Fever (Fever, Lassa)
03/2002

Drug/Important Bio-Agent (IBA)

7Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA
09/2012 - 06/2002
6CholesterolIBA
01/2022 - 01/2007
6FurinIBA
08/2008 - 03/2003
5Proteins (Proteins, Gene)FDA Link
01/2021 - 06/2002
5tetrapeptide carbamateIBA
05/2005 - 03/2003
4oxidized low density lipoproteinIBA
01/2021 - 01/2015
4LDL Receptors (LDL Receptor)IBA
01/2021 - 09/2012
3EnzymesIBA
02/2020 - 10/2006
2isoquercitrinIBA
01/2022 - 01/2018
2QuercetinIBA
01/2022 - 01/2016
2LDL CholesterolIBA
01/2021 - 03/2014
2Proprotein Convertase 9IBA
01/2021 - 01/2020
2LDL Lipoproteins (beta Lipoproteins)IBA
01/2018 - 07/2015
2FlavonoidsIBA
01/2016 - 01/2014
2Glucose (Dextrose)FDA LinkGeneric
09/2015 - 01/2015
2Peptide Hydrolases (Proteases)FDA Link
10/2009 - 08/2008
2Membrane Glycoproteins (Membrane Glycoprotein)IBA
08/2008 - 03/2002
2Messenger RNA (mRNA)IBA
11/2005 - 03/2003
2Matrix Metalloproteinase 14 (MT1-MMP)IBA
05/2005 - 08/2004
2IntegrinsIBA
04/2005 - 02/2004
2Integrin alphaVIBA
02/2004 - 03/2003
2protease SIBA
06/2003 - 04/2003
1Antiviral Agents (Antivirals)IBA
01/2022
1Pharmaceutical PreparationsIBA
01/2022
1FlavonolsIBA
01/2022
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
01/2021
1Interleukin-1beta (Interleukin 1 beta)IBA
01/2021
1InflammasomesIBA
01/2021
1Biomarkers (Surrogate Marker)IBA
02/2020
1DNA (Deoxyribonucleic Acid)IBA
01/2020
1Triglycerides (Triacylglycerol)IBA
09/2015
1ChylomicronsIBA
09/2015
1Apolipoproteins B (ApoB)IBA
09/2015
1Lipoprotein Lipase (Diacylglycerol Lipase)IBA
09/2015
1SteroidsIBA
07/2015
1Estradiol (Delestrogen)FDA LinkGeneric
07/2015
1ProinsulinIBA
10/2013
1Insulin (Novolin)FDA Link
10/2013
1Biological ProductsIBA
10/2009
1anthraceneIBA
10/2009
1SterolsIBA
10/2006
1LipidsIBA
10/2006
1Carrier Proteins (Binding Protein)IBA
11/2005
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
05/2005
1Membrane-Associated Matrix MetalloproteinasesIBA
05/2005
1SubtilisinIBA
04/2005
1SARS-CoV spike glycoproteinIBA
01/2005
1Amyloid Precursor Protein Secretases (beta-Secretase)IBA
12/2004
1Amyloid beta-PeptidesIBA
12/2004
1Vascular Endothelial Growth Factor CIBA
06/2003
1Platelet-Derived Growth FactorIBA
04/2003
1platelet-derived growth factor AIBA
04/2003
1Metalloproteases (Metalloproteinases)IBA
06/2002
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
06/2002

Therapy/Procedure

2Therapeutics
04/2003 - 06/2002
1Fat-Restricted Diet (Diet, Fat Restricted)
06/2007
1Endarterectomy (Thromboendarterectomy)
02/2004
1Subcutaneous Injections
06/2003